Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer
Marcela Moisés Maluf Sanguinete, Paula Honório De Oliveira, Agrimaldo Martins-Filho, et al.
Immunological Investigations (2017) Vol. 46, Iss. 7, pp. 677-688
Closed Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson, Rachel A. O’Keefe, Jennifer R. Grandis
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 4, pp. 234-248
Open Access | Times Cited: 2327
Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression
Kristen Fousek, Lucas A. Horn, Claudia Palena
Pharmacology & Therapeutics (2020) Vol. 219, pp. 107692-107692
Open Access | Times Cited: 230
Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update
Subeka Abraham Gnanadass, Yogamaya D Prabhu, Abilash Valsala Gopalakrishnan
Archives of Gynecology and Obstetrics (2021) Vol. 303, Iss. 3, pp. 631-643
Closed Access | Times Cited: 184
IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
Sara G. Manore, Daniel Doheny, Grace L. Wong, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 171
Neutrophil-to-lymphocyte ratio in schizophrenia: A systematic review and meta-analysis
Vasilios Karageorgiou, Gerasimos Panagiotis Milas, Ioannis Michopoulos
Schizophrenia Research (2018) Vol. 206, pp. 4-12
Closed Access | Times Cited: 126
The intersection of COVID-19 and cancer: signaling pathways and treatment implications
Zhi Zong, Yujun Wei, Jiang Ren, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 61
Perspective for Discovery of Small Molecule IL-6 Inhibitors through Study of Structure–Activity Relationships and Molecular Docking
Hossam Nada, Aneesh Sivaraman, Qili Lu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4417-4433
Closed Access | Times Cited: 26
IL‐8 promotes cell migration through regulating EMT by activating the Wnt/β‐catenin pathway in ovarian cancer
Jirui Wen, Zhiwei Zhao, Liwei Huang, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 24, Iss. 2, pp. 1588-1598
Open Access | Times Cited: 71
Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance
Kevin Dzobo, Collet Dandara
OMICS A Journal of Integrative Biology (2020) Vol. 24, Iss. 6, pp. 314-339
Open Access | Times Cited: 54
Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis
Emanuela Anastasi, Antonella Farina, Teresa Granato, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10479-10479
Open Access | Times Cited: 19
Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer
Jagmohan Hooda, Marián Novak, Matthew P. Salomon, et al.
Cancer Research (2018) Vol. 79, Iss. 4, pp. 760-772
Open Access | Times Cited: 47
IL-6 and IL-8 as Prognostic Factors in Peritoneal Fluid of Ovarian Cancer
Isac Souza Silva Rodrigues, Agrimaldo Martins-Filho, Douglas Côbo Micheli, et al.
Immunological Investigations (2019) Vol. 49, Iss. 5, pp. 510-521
Closed Access | Times Cited: 44
Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer
Nirmala Chandralega Kampan, Mutsa Madondo, John Reynolds, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 44
IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells
Shiwen Xu, Chunyan Yu, Xiaoxia Ma, et al.
European Journal of Pharmacology (2020) Vol. 894, pp. 173817-173817
Closed Access | Times Cited: 42
Is Elevated Neutrophil Count and Neutrophil-to-Lymphocyte Ratio a Cause or Consequence of Schizophrenia?—A Scoping Review
Asbjørn Arnesen Sandberg, Vidar M. Steen, Anja Torsvik
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 34
The tumor immune-microenvironment in gastric cancer
Fujin Fang, Tiantian Zhang, Qiong Li, et al.
Tumori Journal (2022) Vol. 108, Iss. 6, pp. 541-551
Closed Access | Times Cited: 23
Mitochondrial fission enhances IL‐6‐induced metastatic potential in ovarian cancer via ERK1/2 activation
Juwon Lee, Youngjin Han, Soochi Kim, et al.
Cancer Science (2024) Vol. 115, Iss. 5, pp. 1536-1550
Open Access | Times Cited: 6
Translational implications of CHRFAM7A, an elusive human-restricted fusion gene
Ivanna Ihnatovych, Ruth-Ann Saddler, Norbert Süle, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 4, pp. 1020-1032
Open Access | Times Cited: 5
The neutrophil-to-Lymphocyte ratio is associated with clinical symptoms in first-episode medication-naïve patients with schizophrenia
Xuan Wang, Xiaofang Chen, Xiaoni Guan, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
GP130 Cytokines in Breast Cancer and Bone
Tolu Omokehinde, Rachelle W. Johnson
Cancers (2020) Vol. 12, Iss. 2, pp. 326-326
Open Access | Times Cited: 34
Interleukin-6 Promotes Epithelial-Mesenchymal Transition and Cell Invasion through Integrin β6 Upregulation in Colorectal Cancer
Qi Sun, Yukui Shang, Fengkai Sun, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-13
Open Access | Times Cited: 34
Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy
Alicja Rajtak, Marta Ostrowska-Leśko, Klaudia Żak, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer
Yu Sunakawa, Yasutoshi Kuboki, Jun Watanabe, et al.
Targeted Oncology (2024) Vol. 19, Iss. 1, pp. 59-69
Open Access | Times Cited: 4
Ginsenoside Rh2 regulates triple-negative breast cancer proliferation and apoptosis via the IL-6/JAK2/STAT3 pathway
Rumeng Ding, Quancheng Kan, Ting Wang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients
Venus Dalal, Raman Kumar, Sunesh Kumar, et al.
Clinica Chimica Acta (2018) Vol. 482, pp. 27-32
Closed Access | Times Cited: 38
Page 1 - Next Page

Scroll to top